Comparison

Retigabine European Partner

Item no. TMO-T2536-25mg
Manufacturer TargetMol
CASRN 150812-12-7
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. M.J. Brodie, et al. Neurology November 16, 2010 vol. 75 no. 20 1817-1824 .
Smiles CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Potassium Channel activator
Available
Molecular Weight
303, 33
Pathways
Membrane transporter/Ion channel
Bioactivity
Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
Receptor
KCNQ2/Q3 channels; KCNQ3/5; KCQN4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close